TransMedics Group, Inc. Common Stock

TMDXNASDAQ • USD
91.38 USD
↘ 0.62 (0.67%)AT CLOSE (03:59 PM EST)
89.50
↘ 1.88 (2.06%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
89.50
↘ 1.88 (2.06%)
🔴Market: CLOSED

Shares of TransMedics Group, Inc. Common Stock (TMDX) are trading at $91.38. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include exceptional Return on Equity (26.2%) and a bearish Death Cross on the long-term moving averages. Valuation metrics place TMDX at a fair price relative to peers.

Technical & fundamental data as of Nov 13, 2026.

Open?$92.39
High?$94.28
Low?$91.17
Prev. Close?$92.00
Volume?840.9K
Avg. Volume?1.1M
VWAP?$92.42
Rel. Volume?0.75x
Bid / Ask
Bid?$85.74 × 100
Ask?$91.00 × 400
Spread?$5.26
Midpoint?$88.37
Valuation & Ratios
Market Cap?3.2B
Shares Out?34.7M
Float?32.2M
Float %?93.1%
P/E Ratio?21.97
P/B Ratio?5.76
EPS?$4.16
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Employees
898
Market Cap
3.2B
Industry
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Listed
2019-05-02
Address
200 MINUTEMAN ROAD
ANDOVER, MA 01810
Phone: (978) 552-0900
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
40
Z-Score?
66
Momentum?
87
Short Sent.?
30
Piotroski F-Score?4/9Mixed
Altman Z-Score?2.84Grey
Confidence?64%Moderate
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?27.60%Squeeze Risk
Short Interest?8.9M
Days to Cover?10.2
Free Float32.2M
Avg Daily Volume869.1K
Settlement Date2026-10-30
Financial Health
Current Ratio?4.53Strong
Quick Ratio?4.15Strong
Cash Ratio?3.22Strong
Debt/Equity?1.56High
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
56/100
P/E?
Peers
100
S&P
58
22.0FAIR▾
P/B?
Peers
100
S&P
32
5.76FAIR▾
P/S?
Peers
100
S&P
35
4.36FAIR▾
P/FCF?
Peers
100
S&P
3
71.0PRICEY▾
EV/EBITDA?
Peers
100
S&P
12
27.9HIGH▾
EV/Sales?
Peers
100
S&P
37
4.87FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
75
26.2%STRONG▾
ROA?
Peers
50
S&P
73
9.5%STRONG▾
Cash Flow & Enterprise
FCF?$44.7M
Enterprise Value?$3.5B
Fundamentals ratios updated end of day